SynDevRx

Developer of therapeutic approaches designed to target the metabolic drivers and vascular factors that influence cancer progression. The company offers treatments grounded in metabo oncology and suppo...

Healthcare

Cambridge, MA, United States

Founded 2007

5 employees

Website

Valuation

$120M

Market implied

Share Price

N/A

Total Raised

$124.2M

Last Round

N/A

Investors

+1 other investors

View all 1 investors

Valuation History

0 funding rounds on record

Cap Table

Ownership structure

Market Activity

Secondary transactions

Get the full picture

Create a free account to unlock SynDevRx's funding history, team members, investor details, and more.

15 free profiles/month · No credit card required